Form 4: Medicinoiva Director, Nicole Lemerond, Acquires Stock Options
SEC Form 4 Filing
Director Nicole Lemerond acquired stock options in Medicinoiva, Inc. on February 12, 2025.
Summary
- Nicole Lemerond, a director of Medicinoiva, Inc., acquired 24,500 stock options on February 12, 2025.
- The exercise price of these options is $1.84.
- The options vest in four equal installments starting May 12, 2025, and ending February 12, 2026, contingent upon continued service with the company.
- The options expire on February 11, 2035.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders, as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: Nicole Lemerond acquired stock options. |
| 05/12/2025 | First vesting date for the stock options. |
| 08/12/2025 | Second vesting date for the stock options. |
| 11/12/2025 | Third vesting date for the stock options. |
| 02/12/2026 | Fourth vesting date for the stock options. |
| 02/11/2035 | Expiration date of the stock options. |
| 02/14/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.